Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JCO Oncology Practice|July 6, 2026
Acupuncture in Cancer Care: Evidence, Safety, and Implementation in Oncology PracticeWeidong Lu, Eunbin Kwag, Irene Martyniuk, et al.
Integrative Cancer Therapies|March 12, 2024
Genome-wide Analysis Identified SEMA4D, Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung CancerJung-Hyang Park, Eunbin Kwag, Mi-Kyung Jeong, et al.
Integrative Cancer Therapies|August 24, 2023
Effect of Traditional Korean Medicine Oncotherapy on the Survival, Quality of Life, and Telomere Length: A Prospective Cohort StudySu-Jung Ha, Eunbin Kwag, Soodam Kim, et al.
Integrative Cancer Therapies|September 30, 2025
Patients' Expectations and Barriers Toward Reishi Mushroom Use in Cancer Care: A Cross-Sectional SurveyXiaotong Li, Anna Ye, Eunbin Kwag, et al.
Integrative Medicine Research|September 2, 2025
Acupuncture versus cognitive behavioral therapy for anxiety among cancer survivors with insomnia: An exploratory analysis of a randomized clinical trialEunbin Kwag, Xiaotong Li, Sheila Garland, et al.
Journal of Pain and Symptom Management|July 18, 2026
Acupuncture vs Massage for Insomnia and Pain in Advanced Cancer: Exploratory RCTEunbin Kwag, Rose Wy Fok, Qing SLi, et al.
Integrative Cancer Therapies|September 26, 2023
Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin RashWon Kil Lee, Jisoo Myong, Eunbin Kwag, et al.
Current Oncology Reports|November 7, 2025
Complementary Chinese Herbal Medicine Use and Gastrointestinal Cancers: A Scoping Review of Usage Patterns and Survival Outcomes in Taiwanese Population-Based StudiesChun Sing Lam, Eunbin Kwag, Susan Chimonas, et al.
Diseases (Basel, Switzerland)|September 26, 2025
Utilization Pattern of Acupuncture and Its Associated Predictors for Cancer Pain in South Korea: A Cross-Sectional StudyEunbin Kwag, Haneum Joo, Soo-Dam Kim, et al.
Integrative Cancer Therapies|August 5, 2024
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR MutationsEunbin Kwag, Soo-Dam Kim, Seong-Hoon Shin, et al.
Pageof 1